USFDA completes inspection at Laurus Labs’ API facilities in Visakhapatnam

14 Jun 2019 Evaluate

US Food and Drug Administration (USFDA) has completed inspection at Laurus Labs’ API facilities in Units 1 & 3 at Parawada, Visakhapatnam, Andhra Pradesh, with two observations which are procedural in nature. This is a regular surveillance audit by USFDA, and no data integrity issues were observed in the inspection.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

1005.40 -9.50 (-0.94%)
15-Dec-2025 14:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.75
Dr. Reddys Lab 1281.15
Cipla 1505.80
Zydus Lifesciences 921.70
Lupin 2088.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×